Ashland Inc. logo

Ashland Inc. (ASH)

Market Closed
1 Sep, 20:00
NYSE NYSE
$
75. 64
+2.31
+3.1501%
$
3.46B Market Cap
25.2 P/E Ratio
1.62% Div Yield
722,710 Volume
3.83 Eps
$ 73.33
Previous Close
Add Transaction
Day Range
72.67 76.02
Year Range
46.3 78.25
Want to track ASH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ASH closed today higher at $75.64, an increase of 3.1501% from yesterday's close, completing a monthly increase of 4.692% or $3.39. Over the past 12 months, ASH stock gained 27.7919%.
ASH pays dividends to its shareholders, with the most recent payment made on Jun 15, 2026. The next announced payment will be in In 1 weeks on Sep 15, 2026 for a total of $0.42.
The last earnings report, released on Apr 28, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.3839%, based on the last three reports.
Ashland Inc. has completed 5 stock splits, with the recent split occurring on May 15, 2017.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NYSE (USD).

ASH Chart

People also search for

Murphy USA Inc.
$ 536.45
+4.0862%
EAT
Brinker International Inc.
$ 233.98
+2.3982%
Aptiv PLC
$ 44.85
+0.2011%
DDS
Dillard's Inc.
$ 626.36
+0.0623%
WLK
Westlake Corporation
$ 74.23
-1.119%
Ashland (ASH) Up 2% Since Last Earnings Report: Can It Continue?

Ashland (ASH) Up 2% Since Last Earnings Report: Can It Continue?

Ashland (ASH) reported earnings 30 days ago. What's next for the stock?

Zacks | 5 days ago
ASH Launches Permexa Sodium Caprate to Support Oral Biologics Growth

ASH Launches Permexa Sodium Caprate to Support Oral Biologics Growth

Ashland launches Permexa sodium caprate to support oral peptide and biologic development with enhanced processing and permeability.

Zacks | 1 week ago
Ashland Q3 Earnings Call Highlights

Ashland Q3 Earnings Call Highlights

Ashland NYSE: ASH reported higher sales across all four business units in its fiscal third quarter of 2026, supported by volume growth, pricing actions and demand in its Life Sciences and Personal Care operations. The company reaffirmed its full-year sales and adjusted EBITDA outlook, while lowering its adjusted earnings-per-share growth forecast because of a higher tax rate tied to unfavorable discrete items.

Marketbeat | 1 month ago

Ashland Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Timothy M. Bidwell
Timothy M. Bidwell Hazlett, BURT & WATSON Inc.
200 $9,582 $14,522 $4,940 51.55%
Curtis Ellergodt
Curtis Ellergodt Rothschild Investment LLC
640 $32,244.13 $46,284.8 $14,040.67 43.54%
BZ
Brandon Zatopek Commonwealth Equity Services LLC
19,835 $1.31M $1.52M $209,465.75 16.03%
ABB
Alexander Bjornager Bonde Danske Bank A/S
300 $17,601 $22,935 $5,334 30.31%
JD
Jim Dushek HARBOUR INVESTMENTS Inc.
2,761 $264,739.11 $205,915.38 -$58,823.73 -22.22%

Ashland Inc. (ASH) FAQ

What is the stock price today?

The current price is $75.64.

On which exchange is it traded?

Ashland Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is ASH.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.62%.

What is its market cap?

As of today, the market cap is 3.46B.

Has Ashland Inc. ever had a stock split?

Ashland Inc. had 5 splits and the recent split was on May 15, 2017.

Ashland Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Guillermo Novo CEO
NYSE Exchange
044186104 CUSIP
US Country
2,900 Employees
1 Sep 2026 Last Dividend
15 May 2017 Last Split
6 Apr 1983 IPO Date

Overview

Ashland Inc. is a global leader in providing additives and specialty ingredients, with a broad operational footprint that spans North and Latin America, Europe, the Asia Pacific, and other international markets. The company is organized into four main segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Ashland’s offerings cater to a diverse array of consumer and industrial markets, including but not limited to architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical sectors. Initially known as Ashland Global Holdings Inc., the business underwent a rebranding to Ashland Inc. in August 2022. With roots dating back to 1924, Ashland has grown to establish its headquarters in Wilmington, Delaware, marking its significance in the industry through innovation, customer focus, and a robust portfolio of products.

Products and Services

  • Life Sciences Solutions:

    This segment is focused on delivering high-quality pharmaceutical solutions that include controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders. In nutrition, Ashland offers thickeners, stabilizers, emulsifiers, and additives. Additionally, the nutraceutical solutions encompass products aimed at weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness. Ashland also provides custom formulation, toll processing, and particle engineering services catering to specific customer needs.

  • Personal Care Solutions:

    Ashland delivers an array of nature-based, biodegradable, and performance ingredients in the personal care segment. These solutions support a wide range of applications, such as toothpastes, mouth washes and rinses, denture cleaning, and care products for teeth. Moreover, the company offers household suppliers with nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers, aiming at elevating the standard and efficiency of personal and household care products.

  • Specialty Additives:

    This segment encompasses a variety of products like rheology modifiers, foam control agents, surfactants and wetting agents, and pH neutralizers. Furthermore, it includes advanced ceramics used in catalytic converters, environmental filters, materials for the manufacturing of ceramic capacitors, plasma display panels, solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. These additives are designed to enhance the performance and effectiveness of products across diverse industries.

  • Intermediates:

    Ashland's Intermediates segment produces crucial chemicals such as 1,4 butanediol and related derivatives, including n-methylpyrrolidone. These intermediates play a vital role in various manufacturing processes, serving industries ranging from pharmaceuticals to advanced materials and beyond.

Contact Information

Address: 8145 Blazer Drive
Phone: 302 995 3000